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Introduction
Patients with chronic obstructive pulmonary disease
(COPD) exhibit functional limitations, including
decreases in ambulatory and physical activity).1-4 On
average, patients with COPD demonstrate 57% of
thedailyphysical activityperformedby theirhealthy
counterparts.4 Compared to older adults with other
chronicdiseasesordisability,patientswithCOPDhave
thesecondlowestdailystepcount(2,237stepsperday).5,6
Patients with COPD spend a significantly increased
amountof timesittingor lyingdown, furthermore, in
total,thesepatientswalklessthan1hourperday.4
Likely,disuseinpatientswithCOPDleadstoabnor-
malities in gait or walking patterns. Abnormalities







this population. Moreover, in a limited number of
individuals,wehavepreviouslyinvestigatedbiomechanical
gaitabnormalitiesinpatientswithCOPDandcontrols.8











theirmain limitation to physical activity10, 11 and it is
feasible that muscular fatigue is contributing to gait
abnormalities. A primary factor leading to muscular









are uncertain and are not clearly delineated. Disuse
and/or systemic inflammation are believed to play a
role.21 Additionally,gaitabnormalitiesinpatientswith
For personal use only. Permission required for all other uses.
COPDcouldbemore than justaconsequenceof the
muscularalterations.Itisplausiblethatinefficientgait












higher.26 Thus, it has beenproposed that a complete
theoreticalframeworktoidentifyfallriskfactorsinCOPD




tion dramatically improves patient well-being with
beneficial effects on strength, exercise tolerance (not
physicalactivityperse),dyspneaandself-efficacy.29,31














thisexploratorystudywas toassess the feasibilityof
assessing gait biomechanics in patients with COPD
andtodetermineifobservedtrendsinimprovements
following intervention could be found. To do this,










135 Effect of Exercise Intervention on Gait in COPD
















pleted without a bronchodilator. Participants were
excludediftheypresentedwiththehistoryofbackor




instructions and physically perform the experimental






tion.All cardio-respiratory stress testswere readby a
pulmonary physician and specific recommendations
relatedtoexercisewereincorporatedintotheirinterven-
tion(i.e.,oxygenuseduringexercise)whennecessary.




reviewboardand the institutional reviewboardat the
OmahaVAMedicalCenterapprovedallprocedures.
Data Collection
All participants  underwent gait analysis testing
beforeandafteranexerciseintervention.Retro-reflective
markerswereplacedonanatomicallocations,bilaterally,
according to a modified Helen Hayes marker set.43
Participants were asked to walk through a 10-meter
walkwayat anormalpace.Toensure that a complete
footfall would be collected during each trial, starting
positionsforeachlimbweredeterminedpriortodata
collection.Five trialswere collected for each limb, 10



















muscular fatigue). Once the participant reported the
presenceoftiredness,theywereimmediatelyremoved
from the treadmill and asked to walk through the
10-meterwalkway,5timesforeachlimb,withnorestin
betweentrials(non-restedcondition).




ranged from 2 to 8 Hz. Visual 3D (C-Motion, Inc.,
Germantown,Maryland)wasusedforcalculationofjoint








from calculated joint curves (Table 2). In addition,
spatiotemporal gait parameterswere calculated from
customMatLabprograms(Table2).Gaitdatacollections
Table 1. Participant  Demographics
Pre Mean (SD) Post Mean (SD)




Weight(kg) 95.44(33.09) 95.95(34.56) -0.521 6 0.621
FEV1/FVC 0.59(0.10) 0.57(0.11) 0.968 5 0.378
FEV1%Predicted 56.33(20.27) 62.00(12.49) -0.954 5 0.384
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F 1,6 p F 1,6 p F 1,6 pMean Mean (SD)
PeakAnklePowerAbsorption1(J/kg) -0.52(0.29) -0.57(0.41) -0.63(0.38) -0.66(0.45) 6.00 0.05 0.58 0.47 0.04 0.86
PeakAnklePowerAbsorption2(J/kg) -0.82(0.36) -0.84(0.31) -0.81(0.28) -0.88(0.32) 0.28 0.62 0.80 0.41 0.43 0.54
PeakAnklePowerGeneration(J/kg) 2.55(0.46) 2.47(0.41) 2.48(0.43) 2.47(0.39) 0.20 0.67 0.46 0.52 0.20 0.67
PeakKneePowerAbsorption1(J/kg) -0.75(0.43) -0.89(0.42) -0.83(0.39) -0.99(0.53) 10.55 0.02a 10.16 0.02a 0.003 0.96
PeakKneePowerGeneration(J/kg) 0.39(0.15) 0.49(0.24) 0.47(0.23) 0.54(0.24) 1.13 0.33 13.22 0.01a 0.20 0.67
PeakKneePowerAbsorption2(J/kg) -0.67(0.49) -0.69(0.49) -0.78(0.63) -0.72(0.49) 1.50 0.27 0.12 0.74 0.59 0.47
PeakHipPowerGeneration1(J/kg) 0.40(0.20) 0.53(0.29) 0.44(0.22) 0.52(0.31) 0.02 0.89 4.81 0.07 1.47 0.27
PeakHipPowerAbsorption(J/kg) -0.57(0.31) -0.56(0.20) -0.55(0.41) -0.52(0.38) 0.05 0.82 0.12 0.74 0.05 0.83
PeakHipPowerGeneration2(J/kg) 0.63(0.35) 0.64(0.34) 0.76(0.46) 0.70(0.35) 2.15 0.19 0.45 0.53 1.54 0.26
(Note:a indicatessignificancep<0.05.)
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press, 4) leg flexion, and 5) leg extension. Patients
performed4to6repetitionsat70to85%oftheirbaseline
1-RM. Increases in weight were done as participants




with COPD patients where such a protocol was well







2 x 2 fully repeated measures analysis of variance









All participants underwent a cardio-respiratory
stress test prior to starting the exercise intervention.
Only2participantswererequiredtouseoxygenduring
theirexerciseroutines.Nootherrecommendationsor
















Significant main effects for condition (rest vs.











early stance andpeak kneepowergenerationduring
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Figure 1: Ankle Mean Ensemble Curves for the Stance Phase of Gait:A)jointangle,B)jointmomentandC)jointpower.No
significantdifferenceswerefoundforanydependentvariablesattheankle.
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Figure 2: Knee Mean Ensemble Curves for the Stance Phase of Gait:A)jointangle,B)jointmomentandC)jointpower.
(Note:*indicatessignificancep<0.05attheindicatedpeakvaluebetweenrestandnon-restedconditions.
^indicatessignificancep< 0.05attheindicatedpeakvaluebetweenpreandpostconditions.)
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Figure 3: Hip Mean Ensemble Curves for the Stance Phase of Gait: A)jointangle,B)jointmomentandC)jointpower.
(Note:*indicatessignificancep<0.05attheindicatedpeakvaluebetweenrestandnon-restedconditions.)
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F 1,6 p F 1,6 p F 1,6 pMean Mean (SD)
Speed(m/s) 1.14(0.23) 1.18(0.22) 1.15(0.19) 1.21(0.18) 0.40 0.55 20.47 0.004a 1.01 0.36
StepLength(mm) 657.85(77.96) 670.71(87.17) 650.59(54.14) 671.90(66.99) 0.06 0.81 13.07 0.01a 4.31 0.08
StepWidth(mm) 125.04(41.24) 109.20(40.35) 119.04(48.32) 117.22(45.35) 0.11 0.75 4.54 0.08 9.33 0.02a
StepTime(seconds) 0.59(0.09) 0.58(0.06) 0.58(0.07) 0.57(0.05) 1.51 0.27 2.13 0.20 0.38 0.56
StanceTime(seconds) 0.71(0.15) 0.68(0.10) 0.69(0.11) 0.67(0.08) 0.90 0.38 1.74 0.24 0.38 0.56
DoubleSupportTime(seconds) 0.12(0.05) 0.11(0.04) 0.12(0.03) 0.11(0.03) 0.08 0.79 1.86 0.22 0.17 0.70
StrideLength(m) 1.31(0.17) 1.34(0.18) 1.30(0.12) 1.35(0.14) 0.003 0.96 11.43 0.02a 0.74 0.42
StrideTime(seconds) 1.17(0.18) 1.14(0.13) 1.14(0.14) 1.12(0.11) 1.22 0.31 1.65 0.25 0.28 0.61
(Note:a indicatessignificancep< 0.05.)










F 1,6 p F 1,6 p F 1,6 pMean Mean (SD)
PeakPlantarflexionAngle(deg) -5.62(3.17) -5.20(3.39) -4.66(2.65) -5.03(2.43) 0.12 0.74 0.008 0.93 4.38 0.08
PeakDorsiflexionAngle(deg) 13.83(2.96) 14.46(3.53) 15.50(2.79) 15.65(2.57) 0.79 0.41 0.50 0.51 0.59 0.47
PeakKneeFlexionAngle(deg) 15.33(7.90) 17.95(7.00) 15.28(6.95) 15.98(7.53) 1.01 0.35 25.19 0.002a 2.48 0.17
PeakKneeExtensionAngle(deg) 4.48(6.60) 4.78(3.33) 2.82(2.80) 2.49(3.41) 1.51 0.27 0.00 0.99 0.15 0.72
PeakHipFlexionAngle(deg) 35.95(9.10) 38.13(7.75) 36.18(5.50) 37.20(6.78) 0.08 0.79 6.66 0.04a 0.78 0.41
















demonstrate a change in performance during the
non-restedconditionandthishypothesiswassupported
by the findings, especially at the knee joint. The







with COPD demonstrate abnormalities in gait such
asanobservedlimporshuffleandtheseabnormalities
areassociatedwithdiseaseseverity.7 InYentes,etal,





function at the hip joint in order to compensate for
thelossoffunctionattheanklejoint.Thistypeofprofile
hasbeensuggestedtobeaneuromuscularadaptation
toaging,9,49 disease50 andtask.51 Theneuromuscularsystem





similar to the protocol utilized in the current study.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would be noted across all joints. Rather, significant
changeswereonlyseenattheknee.
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F 1,6 p F 1,6 p F 1,6 pMean Mean (SD)
PeakDorsiflexionMoment(Nam/kg) -0.30(0.08) -0.30(0.07) -0.34(0.09) -0.33(0.10) 1.89 0.22 0.25 0.63 0.06 0.82
PeakPlantarflexionMoment(Nam/kg) 1.41(0.11) 1.33(0.13) 1.36(0.14) 1.34(0.11) 0.14 0.72 4.50 0.08 1.00 0.36
PeakKneeExtensionMoment(Nam/kg) 0.63(0.11) 0.70(0.13) 0.63(0.10) 0.68(0.14) 0.11 0.76 17.21 0.006a 0.16 0.70
PeakKneeFlexionMoment(Nam/kg) -0.19(0.17) -0.19(0.19) -0.18(0.16) -0.19(0.21) 0.001 0.97 0.006 0.94 0.58 0.48
PeakHipExtensionMoment(Nam/kg) 0.50(0.15) 0.55(0.12) 0.54(0.12) 0.57(0.14) 0.94 0.37 3.44 0.11 0.37 0.57
PeakHipFlexionMoment(Nam/kg) -0.77(0.32) -0.72(0.22) -0.71(0.29) -0.69(0.25) 0.16 0.70 1.28 0.31 0.41 0.55
(Note:aindicatessignificancep< 0.05.)
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Moreplausibly,thechangesatthekneeareduetothe













density.52 In addition, muscle fiber type shifting has






























that an indirect mechanism is at play. Although not
collected for the current study, it is possible that the
interventionprovidedthepatientsconfidenceinterms








Thereareseveral limitations in thecurrentstudy.
First,itispossiblethattheincreasesinstrengthreported
inthisstudyareduetoneuromuscularimprovements





























limited thefindings in thepre- vs. post-testing.The
currentinterventionwaschosenbasedonotherexercise
interventionstudieswithCOPDpatientswheresucha
protocol was well tolerated47,48 and according to the







that isvitalat the terminaldouble supportphaseof
gait.Infact,patientswithvasculardiseasedemonstrate
abnormalgaitpatternsandithasbeenreasonedthat
For personal use only. Permission required for all other uses.
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abnormalities with disease severity in COPD using
NHANES.Gaitabnormalitiesreportedinthisdataset
were based upon physician observation or patient
self-report.Anotherstudyassessedalimitednumberof
individuals with COPD and controls.8 Although no
differenceswerefoundinpatientswithCOPDcompared













found for the intervention, interestingfindingsat the
kneeinrestvs.non-restedconditionsandchangesin
stepwidthweredemonstrated.Itdoesappearthough
that the lack of rest has a dramatic influence on the
abilityofCOPDpatientstowalk,especiallyattheknee
joint.Thisisconsistentwiththereportedhistological
and biochemical alterations in quadricepmuscles of
individualswithCOPD.Importantly,thecurrentstudy
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